Miltefosine for Brazilian Visceral Leishmaniasis

NCT00378495 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

80

Enrollment

OTHER

Sponsor class

Stopped accrual criteria being reviewed

Conditions

Kala Azar

Interventions

DRUG: Miltefosine: initially 2.5 mg/kg/day for 28 days

Sponsor

AB Foundation

Collaborators

[object Object]